TokenPost·
Vaxcyte Posts $1.99 Q3 GAAP Loss Per Share, 15 Cents Better Than Estimate
Cash, cash equivalents and investments totaled $2,264.4 million on Sept. 30, down from $2,442.6 million at year-end 2025.
More news
- TokenPostDemocrats Flip Seven Senate Seats and at Least 24 House Districts
- TokenPostIsomorphic Labs Seeks About $5 Billion at About $50 Billion Valuation
- TokenPostTreasure Proposal Sets 173 Million MAGIC Ceiling for DePIN Fund
- TokenPostHecla Expects Keno Hill Throughput Near 300 Metric Tons a Day in Q4 2026
- Crypto BriefingIREN’s Texas data center for Microsoft falls behind schedule
- TokenPostJapan's Nikkei 225 Falls 6.72% as SoftBank Shares Slide 14%